Algopedol® Sucrose 24%
Sterile, GMP-manufactured 24% oral sucrose solution (EPMC Pharma) – 2 ml single-use vials for procedural analgesia in term and preterm neonates.
Procedural pain in NICU and postnatal care is frequent and consequential, and oral sucrose has Cochrane-reviewed evidence of efficacy across heel lance, venipuncture, and intramuscular injection in preterm and term neonates. Algopedol® acts via a sweet-taste-mediated endogenous analgesic pathway, producing measurable antinociceptive effect within approximately 2 minutes of administration, with a duration of around 5-10 minutes.
The product is manufactured under pharmaceutical GMP as a sterile oral solution – a meaningful distinction in an immunocompromised population where extemporaneous preparations introduce microbiological risk.
- Cochrane-reviewed procedural efficacy – Evidence across heel lance, venipuncture, and intramuscular injection in preterm and term neonates.
- 2-minute onset, 5-10 minute duration – Aligned to the procedural window without prolonged sedation.
- Sweet-taste-mediated endogenous analgesic pathway – Non-pharmacologic mechanism via sweet-taste receptor activation rather than systemic drug delivery.
- Sterile GMP manufacture – Reduces microbiological risk associated with extemporaneous preparations.
- 2 ml single-use vials – precise unit-dose administration without wastage or cross-contamination.
- 3-year shelf life – supports ward-level stock management.
- Oral route – no additional equipment, specialist skills, or venous access required.
Used for procedural analgesia in term and preterm neonates undergoing painful procedures including heel lance, venipuncture, and intramuscular injection. Enables evidence-based, opioid-free analgesia administered as a sterile, GMP-manufactured oral solution.
